CellTran

company

About

CellTran is a biotechnology company engaged in the development of cell therapy products for the wound management industry.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£1M
Industries
Biotechnology,Health Care,Manufacturing
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

CellTran Limited engages in the research and development of products for the regeneration of tissue and the healing of wounds. The company offers Myskin that is used for the treatment of difficult to heal wounds; Lyphoderm, a freeze-dried lysate from cultured human keratinocytes that is formulated into a hydrophilic gel; and Ulcodress, an integrated wound care dressing that provides control of moisture, infection, and proteases within the wound area. It provides skin banking services, as well as contract manufacture services in the fields of materials fabrication and cell culture. The company was founded in 2000 and is based in Sheffield, the United Kingdom. As of October 28, 2008, CellTran Limited operates as a subsidiary of York Pharma plc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£1M $5.29M
CellTran has raised a total of £1M $5.29M in funding over 2 rounds. Their latest funding was raised on Aug 21, 2007 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 21, 2007 Series Unknown £1M 1 Detail
Aug 9, 2005 Series Unknown $4.82M 2 Detail
Feb 1, 2005 Series Unknown $470K 1 Detail

Investors

Number of Lead Investors
Number of Investors
4
CellTran is funded by 4 investors. PUK Ventures and Spirit Capital Partners are the most recent investors.
Investor Name Lead Investor Funding Round
PUK Ventures Series Unknown
Spirit Capital Partners Series Unknown
Partnerships UK Series Unknown
SMH Venture Finance Limited Series Unknown